U.S. Healthtech Stock News

SpaceX’s blockbuster US$85.7b IPO and its push toward space based AI data centers have put a fresh spotlight on the semiconductors and chip manufacturers that could sit behind these projects. With launch costs under pressure and big tech exploring orbital infrastructure, the supply chain for high performance chips is back in focus. This article looks at 3 stocks from our Semiconductor and Chip Manufacturers screener that appear closely exposed to this news, to help you consider whether these...

With markets fixated on every twist in US inflation data, May PCE has become a key reference point for anyone watching the US dollar and interest rate expectations. Stronger PCE could keep rate pressures elevated and support a firmer dollar, while softer readings might ease the outlook for hikes and take some heat off rate sensitive assets. This article looks at 3 stocks from our US Dollar Strength Plays screener that are closely tied to these themes and may help you assess whether their...

Lear (LEA) has attracted fresh attention as investors weigh mixed technical signals against much stronger recent financial results, with quarterly revenue up 4.72% and net profit growth above 100% drawing closer scrutiny to the stock. See our latest analysis for Lear. At a share price of $139.75, Lear has given investors a 17.56% 3 month share price return and a 57.5% 1 year total shareholder return. This suggests momentum has been building as recent earnings and mixed technical signals reset...

The US Energy Sector is in the spotlight again as crude oil prices move below US$80 per barrel on the back of a tentative US Iran deal, even while tensions around the Strait of Hormuz and higher interest rates keep risk elevated. For investors, that mix of lower oil prices, stubborn 4.2% US inflation, and diverging central bank policies can reshape how US based energy stocks trade and behave. This article looks at 3 stocks from a US Energy Sector screener that appear particularly exposed to...

Some Talen Energy Corporation ( NASDAQ:TLN ) shareholders may be a little concerned to see that the Independent...

Stellar Bancorp (STEL) is back on traders’ screens after recent data highlighted year-over-year gains in revenue and net profit, a solid financial health score, and technical signals pointing to ongoing positive price momentum. See our latest analysis for Stellar Bancorp. At a share price of $38.43, Stellar Bancorp has recorded a 24.93% year to date share price return. The 1 year total shareholder return of 45.45% and 3 year total shareholder return of 79.73% point to momentum that has been...

In recent months, Oshkosh Corp has seen institutional ownership rise sharply while reporting only a slight year-over-year revenue increase but a very large jump in quarterly net profit, pointing to improved profitability despite only modest top-line growth. This combination of stronger institutional backing and enhanced earnings efficiency is reshaping how investors assess Oshkosh’s financial resilience and quality of performance. We’ll now examine how the surge in institutional ownership...

We wouldn't blame Applied Materials, Inc. ( NASDAQ:AMAT ) shareholders if they were a little worried about the fact...

Persistent inflation, higher energy costs, and record Illinois state spending are all hitting Midwest wallets at once, and the pressure is starting to show up in both consumer behavior and corporate margins. Some stocks could see support from regulated pricing power or essential services, while others may feel the squeeze from rising fuel, freight, and tax burdens. This article walks through three stocks exposed to these inflation and policy trends. It highlights one that may be relatively...

Some Entravision Communications Corporation ( NYSE:EVC ) shareholders may be a little concerned to see that the Board...

FreeCast, Inc. recently announced a reseller agreement for Starlink Business satellite broadband and an expanded DIRECTV distribution partnership across its Platform-as-a-Service and residential channels, aiming to bundle connectivity and premium television for sectors ranging from multifamily housing to municipal deployments. By pairing enterprise-grade broadband with white-label streaming, advertising, and community engagement tools, FreeCast is positioning its platform as a single vendor...

Ukraine’s expanding use of mid and long range drones, Russian production bottlenecks, and pressure on energy and logistics routes are reshaping how investors think about defense and aerospace stocks tied to this conflict. For some companies, higher demand for equipment and support services may be a clear positive, while for others the risks to supply chains and budgets may be harder to quantify. This article breaks down how these cross currents link back to real businesses and discusses 3...

In recent months, Universal Corp has seen institutional ownership rise to 95.24% of shares, alongside higher revenue and a very large jump in net profit, underscoring strong operational efficiency and financial health relative to Food & Tobacco peers. At the same time, the stock’s technical picture has turned bearish despite this robust institutional backing, highlighting an unusual disconnect between trading signals and the company’s improving fundamentals. We’ll now examine how stronger...

Analyst upgrade puts Kanzhun in focus Bernstein’s upgrade of Kanzhun (NasdaqGS:BZ) following its Q1 2026 results has put the stock back on many investors’ radars, with attention on revenue trends, user metrics, and AI driven matching. See our latest analysis for Kanzhun. The upgrade lands after a mixed stretch for Kanzhun, with the share price up 2.62% over 90 days but down 34.48% year to date and the 1 year total shareholder return declining 22.64%. This suggests recent momentum is tentative...

Clinical PSMA Data Sparks Fresh Look At Vir Biotechnology Stock Vir Biotechnology (VIR) has moved back onto investors' radars after new PSMA clinical data in prostate cancer prompted an updated investment thesis and renewed focus on the company’s T cell engager pipeline. See our latest analysis for Vir Biotechnology. At a share price of US$9.16, Vir Biotechnology’s short term picture reflects a mix of optimism and caution, with a 7 day share price return of 6.39% and a year to date share...

SEI Investments (NasdaqGS:SEIC) has created new executive roles to scale its AI and data strategy across the enterprise. The company appointed Matt Provencher as Global Head of Enterprise Professional Services to lead its expanded services organization. SEI is rolling out next generation platforms, AI powered tools, and enterprise wide automation initiatives to support clients. SEI Investments operates at the intersection of technology and investment services, providing platforms and...

Inflation in India is heating up, with wholesale prices at 9.68% in May and higher crude oil costs feeding through to food, transport, and everyday essentials. For investors, that combination can squeeze many businesses, while others may prove more resilient as households continue to prioritise staples. This article looks at how those pressures and potential policy moves from the RBI or government might affect a group of large and mid-cap consumer staples stocks listed in the US, Canada, the...

The Tate & Lyle takeover by US-based Ingredion has turned the spotlight onto consumer staples stocks that could sit on the path of the next merger or acquisition. A £2.7b price tag, a 60% premium to pre-deal speculation levels and plans for a combined $9.9b revenue base are a clear reminder that scale, cost cutting and product portfolios are firmly in focus. This article looks at 3 stocks that appear directly exposed to the same set of forces, helping you decide whether these M&A currents...

Arqit Quantum (NasdaqCM:ARQQ) has agreed to a US$7 million settlement resolving all U.S. securities class actions, closing multi year disputes over alleged misstatements about its quantum encryption technology and revenue sources. See our latest analysis for Arqit Quantum. The recent 7 day share price return of 79.3%, including a 7.9% move in the last session to US$24.38, suggests momentum has picked up quickly, even though the 1 year total shareholder return is still down 41.5% and the 5...

Coca-Cola FEMSA, S.A.B. de C.V. recently declared a quarterly dividend of US$0.9973 per share payable on July 24, 2026, while also confirming a board change with Sedef Salingan Sahin replacing Jennifer K. Mann as a Series D director earlier in June. These moves, alongside recent improvements in revenue and net profit, highlight how the bottler is coupling capital returns with governance continuity and operating strength. With this combination of a higher cash payout and steady operations,...

Recently, Rayonier Inc. reported a valuation score of 8.90, placing it 52nd out of 191 Residential & Commercial REITs, alongside a P/E ratio of 6.90, while institutional shareholdings rose as major investors such as Cohen & Steers Capital Management and BlackRock increased their positions and Mason Hawkins remained the largest holder despite slightly reducing its stake. This combination of a relatively low earnings multiple and rising institutional ownership suggests that professional...

In recent days, Envista Holdings Corp has seen growing institutional ownership, a high valuation multiple, and technical indicators pointing to positive price momentum, all within a relatively low-beta risk profile in the Healthcare Equipment & Supplies industry. An interesting angle is Envista’s combination of a very high institutional shareholding score with limited disclosed valuation metrics beyond its P/E ratio, leaving some aspects of market expectations less transparent. We’ll now...

In its latest quarterly update, Collegium Pharmaceutical reported year-over-year revenue growth of 8.87% and a very large increase in net profit, alongside strong financial scores for profitability, operational efficiency, and growth potential. These results suggest recent spending and operational adjustments are starting to translate into much stronger earnings power, easing earlier concerns about whether the company’s investments would improve profitability. Now we’ll examine how this...

With the Federal Reserve holding rates steady at 3.5% to 3.75% and signaling a steady, data focused approach under Chair Kevin Warsh, many investors are looking again at stable dividend paying blue chip stocks as potential anchors for their portfolios. Policy stability, ongoing geopolitical tension, and volatile oil prices are creating a mixed backdrop, but consistent dividends and stronger balance sheets can help smooth some of that noise. This article walks through three stocks from our...